GlobalData
GlobalData

Medical Devices

Influx of electronic component makers into medical devices market will reduce India’s import dependency on China, says GlobalData

COVID-19 outbreak presents an opportunity to electronic component manufacturers in India to foray into medical devices market and reduce the country’s import dependency on China, says GlobalData, a leading data and analytics company. Recently, the Kerala State Electronics Development Corporation (Keltron), a state government-owned company which manufactures electronic equipment, announced foray into medical devices sector […]
Read more

LabCorp’s new antibody test promises COVID-19 discoveries while showing much still to be learned

Following the recent news that LabCorp has launched its neutralizing antibody test for the SARS-CoV-2 virus; Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “LabCorp’s neutralizing antibody assay, which unlike most currently available antibody tests assesses antibody efficacy, represents an important step forward in the fight against […]
Read more

Abbott’s revenue growth to continue during COVID-19 thanks to diabetes care device, says GlobalData

Following the news that Abbott’s Q1 worldwide sales increased 2.5% despite the negative business impact of COVID-19; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Abbott’s diverse product portfolio provides some resilience during the COVID-19 pandemic compared with other companies. Even though Abbott’s Core Laboratory Diagnostics showed […]
Read more

Bridge to heart transplant falls short for patients on ECMO highlighting areas of improvement

Following recent guidance from healthcare regulating agencies to increase available extracorporeal membrane oxygenation (ECMO) devices in hospitals for use as an alternative to ventilators, the newest publishing in JACC showing that ventricular assist devices (VAD) devices outperform ECMO units in bridge to heart transplants reminds manufacturers and doctors about the risk factors associated with ECMO, […]
Read more

COVID-19 Immunity Passports are a misnomer, says GlobalData

Following the announcement of Yourgene Health teaming up with international payments company Caxton and immunity passport app Prova; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “The term ‘immunity passport’ is completely misleading. The correlation between a positive result for a COVID-19 test and protective immunity to […]
Read more

Accelerated testing for COVID-19 slowly becoming a reality with NGS technology, says GlobalData

Illumina receiving emergency use authorisation (EUA) from the Food and Drug Administration (FDA) for diagnosing COVID-19 using its next generation sequencing (NGS) technology could not have come at a more critical period during this pandemic. This breakthrough will most likely provide much needed relief in the global backlog of COVID-19 diagnostic tests, according to GlobalData, […]
Read more

Hospital supplies market in India to witness significant growth over next few quarters, says GlobalData

Easing of lockdown measures, re-opening of outpatient services and gradual increase in the number of surgical procedures performed along with treatment of COVID-19 patients in private healthcare facilities are expected to drive the demand for hospital supplies in the coming quarters in India, says GlobalData, a leading data and analytics company. According to GlobalData’s Medical […]
Read more

Royal Philips obstetrics monitoring product part of shifting landscape to remote monitoring technologies

Following the recent news that Royal Philips has launched its Avalon CL Fetal and Maternal Pod and Patch obstetrics monitoring solution for high-risk expectant mothers; Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “The lockdown measures in place across the globe have created the perfect scenario for […]
Read more

Guidelines for non-emergency elective procedures are released

Following the Centers for Medicare & Medicaid Services (CMS) announcement that guidelines to resume elective procedures for healthcare systems were released: Kamilla Kan, Medical Analyst at GlobalData, a leading data and analytics company, offers her view on the recent news: “In March CMS has released recommendations for healthcare providers to postpone non-emergency elective procedures in […]
Read more

Sapien 3 approval in China fuels growth for Edwards Lifesciences amid COVID-19 pandemic, says GlobalData

Following the news that Edwards Lifesciences has received Chinese regulatory approval for its SAPIEN 3 transcatheter heart valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) at high risk for or unable to undergo open-heart surgery; Ashley Young, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her […]
Read more

Use of real-world data for medical device approval significantly reduces time to market in China, says GlobalData

The National Medical Products Administration (NMPA) of China has recently expanded the list of medical devices exempted from providing locally generated clinical trial data and allowed the use of real-world data for medical device registration. These steps will encourage foreign medical device manufacturers to access the Chinese market as the new process will reduce registration […]
Read more

Neurodiagnostic companies offering one-time use products will experience faster recovery amid pandemic

Following the news that Brain Scientific will be offering a disposable version of its electroencephalogram (EEG) headset, the NeuroCap, in addition to enhanced features; Sheryl Tang, Medical Deices Analyst at GlobalData, offers her view: “Neurodiagnostic procedures have dropped significantly due to the COVID-19 impact for several reasons, including the suspension of elective and non-essential procedures. […]
Read more

Mammography equipment market in APAC to grow at robust CAGR of 25.1% between 2019 and 2028, forecasts GlobalData

The mammography equipment market in the Asia-Pacific (APAC) region is expected to grow at a compound annual growth rate (CAGR) of 25.1% from US$0.6bn in 2019 to US$4.2bn by 2028, according to GlobalData, a leading data, and analytics company. GlobalData’s report, ‘Mammography Equipment – Diagnostic Imaging Market Analysis and Forecast Model’ states that while inclination […]
Read more
1 42 43 44 45 46 51